Success Stories: EB-1A Approved for Postdoctoral Fellow in Massachusetts in the Field of Medical Science
Client’s Testimonial:
I am very very happy. Thank you so much for helping me. I will recommend Chen and only Chen to my friends for their green card application. [...] Again a big THANKS to all of your team members.
On April 22, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Medical Science (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: April 22, 2015
Processing Time: 23 Days (6 Days after Premium Processing Requested)
In this case, the client that we had the opportunity to work with was a postdoctoral fellow from India in the field of medical science. He had conducted his research in the highly specialized area in using proteomics and molecular cell signaling technologies to study chronic diseases. His work had resulted in 29 peer-reviewed scientific articles, 1 book chapter, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 1354 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 5 manuscripts for at least one internationally-circulated journal. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] also fully documented molecular activities using in vivo and in vitro cancer models in the following anti-cancer agents […]. These findings are necessary for advancing targeted cancer drugs which are less expensive, more efficient, and are not harmful to patients.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of medical science, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 23 days.